Allergy & Immunology Doctors in Lafayette, LA Accepting Medicare

8 Allergy & Immunology doctors found. Showing 1 - 8

Dr. Erin Trahan Pratt, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 101 Rue Fontaine Bldg 2, Lafayette, LA 70508 Phone: 337-484-1414    Fax: 337-233-3188

Dr. Alexandra Joseph Chastant, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 320 Settlers Trace Blvd, Lafayette, LA 70508 Phone: 337-981-9495    Fax: 337-981-7451

Mr. Bernard C Fruge Jr., MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 320 Settlers Trace Blvd, Lafayette, LA 70508 Phone: 337-981-9495    Fax: 337-981-7451

Dr. Bina E Joseph, MD Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Accepting Medicare Assignments Practice Location: 320 Settlers Trace Blvd, Lafayette, LA 70508 Phone: 337-981-9495    Fax: 337-981-7451

Dr. Wilton Lee Bergeron, M. D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1505 Westgate Rd, Lafayette, LA 70506 Phone: 337-981-2588

Dr. Elizabeth Bertucci Robertson, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 200 Petroleum Dr, Lafayette, Lafayette, LA 70508 Phone: 337-988-9999    Fax: 337-984-7003

Elizabeth Renee Smith, M.D. Allergy & Immunology - Clinical & Laboratory Immunology Medicare: Accepting Medicare Assignments Practice Location: 101 Rue Fontaine Bldg 2, Lafayette, LA 70508 Phone: 337-484-1414    Fax: 337-233-3188

Dr. Andrew Daniel Collins, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 320 Settlers Trace Blvd, Lafayette, LA 70508 Phone: 337-981-9495    Fax: 337-981-7451

News Archive

Researchers reveal how omega-3 fatty acids inhibit growth of prostate cancer cells

Washington State University researchers have found a mechanism by which omega-3 fatty acids inhibit the growth and spread of prostate cancer cells. The findings, which are at odds with a 2013 study asserting that omega-3s increase the risk of prostate cancer, point the way to more effective anti-cancer drugs.

Eli Lilly starts trial of treatment of mild to moderate Alzheimer's disease

Eli Lilly and Company has announced the start of a Phase III clinical trial studying LY450139, an investigational gamma secretase inhibitor for the treatment of mild to moderate Alzheimer's disease.

Medication adherence interventions for heart failure patients

Unlike some conditions, heart failure must be managed by patients taking prescriptions for the rest of their lives. Individuals who do not take their heart medication as prescribed have increased risks of mortality and hospitalization and higher health care costs.

Findings show promise for developing vaccines against multiple strains of flu, including SARS-CoV-2

A vaccine additive known as an adjuvant can enhance responses to a vaccine containing the exotic avian flu virus H5N1, so that both rookie and veteran elements of the immune response are strengthened, according to results from an Emory Vaccine Center study.

Polyplus-transfection introduces FectoPRO transfection reagent

Polyplus-transfection SA, a privately-held company specializing in the development of innovative solutions for transfection, today announces the launch of FectoPRO, the latest optimised transfection reagent in their product portfolio. FectoPRO has been designed for high yields in medium and large-scale production of proteins and antibodies in mammalian cells.

Read more Medical News

› Verified 7 days ago